Weill Medical College of Cornell University donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country

Donation amounts by donor and year for donee Weill Medical College of Cornell University

Donor Total 2017 2016 2015 2014 2012
Bill and Melinda Gates Foundation (filter this donee) 14,119,408.73 -164,883.27 11,604,543.00 992,837.00 157,500.00 1,529,412.00
Total 14,119,408.73 -164,883.27 11,604,543.00 992,837.00 157,500.00 1,529,412.00

Full list of donations in reverse chronological order (11 donations)

DonorAmount (current USD)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation-493.272017-02-17Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify the genes that control how tuberculosis exits latency by separating damaged proteins from functional proteins for use in screens to find new and more powerful TB therapies.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-164,390.002017-01-20Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to characterize how metabolosomes enable tuberculosis to enter and exit latency and whether they can be used as targets for new drug therapies for TB.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,223,907.002016-11-16Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to assess the safety and performance of the ShangRing in an effort to provide early infant male circumcision in sub-Saharan Africa and thus reduce HIV transmission and HIV incidence; Aid type: Project-type interventions. Affected regions: Africa.
Bill and Melinda Gates Foundation7,280,636.002016-10-03Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to advance the development of prophylactic HIV-1 vaccines based on trimeric forms of the viral envelope glycoproteins designed to induce protective neutralizing antibodies in clinical studies.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002016-04-20Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to monitor the spread of antimicrobial resistance by generating a global map of bacterial species, resistance genes and markers, and modified bases (epigenetics) from samples taken monthly over one year from 24 developed and developing cities; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation992,837.002015-07-16Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to advance the development of prophylactic HIV-1 vaccines based on trimeric forms of the viral envelope glycoproteins designed to induce protective neutralizing antibodies in clinical studies.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation57,500.002014-10-21Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to support the Tuberculosis (TB) Drug Discovery and Development Gordon Research Conference; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.002014-04-15Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to increase male circumcision rates to reduce HIV incidence by exploiting the influence of the church to educate communities in Tanzania on medical, religious, and social aspects of male circumcision.; Aid type: Project-type interventions. Affected regions: Africa.
Bill and Melinda Gates Foundation100,000.002012-10-23Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop silica nanopore-based assays to capture unique low molecular weight proteins and identify biomarkers associated with host resistance to HIV.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation782,724.002012-10-11Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to characterize how metabolosomes enable tuberculosis to enter and exit latency and whether they can be used as targets for new drug therapies for TB.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation646,688.002012-09-18Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to identify the genes that control how tuberculosis exits latency by separating damaged proteins from functional proteins for use in screens to find new and more powerful TB therapies.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.